Dr Emily Gulliver is a member of the Microbiota and Systems Biology Research group in the Centre for Innate Immunity and Infectious Diseases.

Learn more about my group's research

Areas of interest

Antimicrobial resistance COVID-19 Gastroenteritis Inflammatory bowel disease (IBD) Microbiome in health and disease

Research group

Microbiota and Systems Biology

Biography

Dr Emily Gulliver is a postdoctoral scientist in the Microbiota and Systems Biology Laboratory within the Centre for Innate Immunity and Infectious Diseases. Dr Gulliver completed her PhD with A/Prof John Boyce at Monash University where she studied small RNA regulation within the Gram-negative bacterial pathogen Pasteurella multocida. This work identified the role of the sRNA GcvB in amino acid biosynthesis and transport and elucidated the RNA binding partners of the sRNA chaperone protein ProQ within P. multocida. Since 2019, Dr Gulliver has been working on developing microbiological, genomic and sequencing methods to characterise the movement of antimicrobial resistance genes between bacteria that inhabit the human gut.

Publication highlights